Innovus Pharmaceuticals Completes Asset Purchase of Ex-U.S. Rights to CIRCUMserum™

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., April 22, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) www.innovuspharma.com (OTCBB:INNV), today announced that it has completed the acquisition of the global ex-U.S. rights to the proprietary U.S. marketed skin cream, CIRCUMserum™ from Centric Research Institute (“CRI”) for over $7.5 million in upfront, milestones and sales royalty payments.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC